Advertisement
Organisation › Details
Viela Bio Inc.
Start | 2018-02-28 splitoff | |
Predecessor | MedImmune (biologics division of AstraZeneca) | |
Industry | anti-inflammatory drug | |
Industry 2 | drug development | |
Region | Gaithersburg, MD | |
Country | United States (USA) | |
Street | 1 MedImmune Way | |
City | 20878 Gaithersburg, MD | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Record changed: 2023-07-10 |
Advertisement
More documents for Viela Bio Inc.
- [1] Horizon Therapeutics plc. (2/1/21). "Press Release: Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio". Dublin & Gaithersburg, MD....
- [2] AstraZeneca plc. (2/28/18). "Press Release: MedImmune to Create Stand-alone Company for Early-stage Inflammation and Autoimmunity Biologics"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top